Loading organizations...
Loading organizations...
Develops multi-functional antibodies for next-gen cancer therapies.
DotBio has raised $5.6M across 1 funding round.
DotBio has raised $5.6M in total across 1 funding round.
DotBio has raised $5.6M in total across 1 funding round.
DotBio's investors include Beilin Le, Haolin Sung, Sujuan Ba, Chaperone Investment, Protect Biotech.
DotBio has raised $5.6M across 1 funding round. Most recently, it raised $5.6M Pre-Series A in August 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 10, 2023 | $5.6M Pre-Series A | Beilin Le, Haolin Sung | Sujuan Ba, Chaperone Investment, Protect Biotech |